|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01548 GENSCRIPT BIO
Nominal 
11.230 +0.140 (+1.262%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -10.518% | 68.360% | -3.218% | -9.491% | -19.488% |
| ROAE (%) | -12.870% | 103.703% | -7.951% | -22.061% | -36.834% |
| Return on Capital Employed (%) | -12.892% | 65.861% | -3.301% | -11.340% | -19.703% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 57.654% | 45.775% | 48.784% | 48.599% | 57.645% |
| EBITDA Margin (%) | -6.130% | -10.455% | -29.545% | -56.600% | -95.898% |
| Pre-tax Profit Margin (%) | -49.038% | -28.730% | -41.807% | -68.993% | -105.564% |
| Net Profit Margin (%) | -55.531% | 498.225% | -11.373% | -36.256% | -73.192% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 1.498 X | 1.069 X | 4.756 X | 3.233 X | 3.966 X |
| Quick Ratio (X) | 1.443 X | 1.029 X | 4.648 X | 3.123 X | 3.858 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 18.309% | 18.091% | 39.647% | 46.486% | 37.879% |
| Total Debt / Total Assets (%) | 5.333% | 3.232% | 12.310% | 13.737% | 7.004% |
| Net Debt / Total Assets (%) | 2.397% | 0.731% | -30.390% | -26.477% | -45.863% |
| Total Debt / Shareholders' Funds (%) | 6.537% | 3.947% | 29.976% | 34.615% | 14.957% |
| Long Term Debt / Shareholders' Funds (%) | 1.389% | 1.719% | 25.240% | 30.183% | 14.189% |
| Net Debt / Shareholders' Funds (%) | 2.939% | 0.893% | -74.001% | -66.717% | -97.947% |
| Net Cash / (Debt) ($) | (116.349M) | (38.578M) | 1.029B | 674.200M | 1.025B |
| Net Cash / (Debt) per share ($) | (0.053) | (0.018) | 0.485 | 0.319 | 0.488 |
| Total Debt / Capital Employed (%) | 6.263% | 3.793% | 14.416% | 17.486% | 8.593% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 31.751 Day | 47.806 Day | 48.081 Day | 59.181 Day | 66.909 Day |
| Receivables Turnover (Day) | 47.592 Day | 102.878 Day | 70.238 Day | 71.961 Day | 105.824 Day |
| Payables Turnover (Day) | 12.672 Day | 21.427 Day | 20.807 Day | 25.064 Day | 19.941 Day |
| Remarks: | Real time quote last updated: 16/03/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -532,830 |
| %Change | -- |
| EPS / (LPS) | USD -0.246 |
| NBV Per Share ($) | USD 1.811 |